Hinge Health reports record third quarter 2026 financial results
Hinge Health reported record Q3 2026 revenue of $235 million, up 52% year-over-year, with GAAP income from operations swinging to $50.3 million from a $6.1 million loss a year ago. Free cash flow reached $112.7 million (48% margin), and LTM calculated billings grew 54% to $960.3 million with clients up 28% to 3,270. The company raised FY2026 guidance to $879-$881 million revenue (50% YoY growth) with a 30% non-GAAP operating margin midpoint, roughly 1,000 bps of annual improvement, citing a record sales season and strong momentum in MSK, GI, and Migraine Care Programs following the Cylinder Health acquisition.
Key figures
- Eps
- 0.66
- Revenue
- 235000000
- Guidance
- Q4 2026 revenue $249M-$251M (46% YoY at midpoint); FY2026 revenue raised to $879M-$881M (50% YoY at midpoint); FY2026 non-GAAP income from operations raised to $266M-$268M with 30% non-GAAP operating margin
- Revenue Yoy
- 52%
- Fcf
- 112658000
- Clients
- 3270
- Fcf margin
- 48%
- Clients yoy
- 28%
- Non gaap eps
- 0.71
- Ltm billings yoy
- 54%
- Gaap gross margin
- 87%
- Gaap operating income
- 50325000
- Non gaap gross margin
- 88%
- Ltm calculated billings
- 960300000
- Non gaap operating income
- 77209000
- Cash and marketable securities
- 358500000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.